Skip to main content Accessibility help
×
Home
  • Print publication year: 2017
  • Online publication date: June 2017

Introduction

1.Moyer, V.A. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. US Preventive Services Task Force. Ann Intern Med. 2012, 156:880–91. Available at: www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Retrieved May 22, 2014.
2.Saslow, D., Solomon, D., Lawson, H.W. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012, 62:147–72. Available at: www.asccp.org/Guidelines/Screening-Guidelines. Retrieved September 26, 2015.
3.Qaseem, A., Humphrey, L.L., Harris, R., Starkey, M., Denberg, T.D.; Clinical Guidelines Committee of the American College of Physicians. Screening pelvic examination in adult women: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014, 161:6772.
4.Siu, A.L; US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(4):279–96.
5.Oeffinger, K.C., Fontham, E.T., Etzioni, R., et al.; American Cancer Society. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015, 314:15991614.
6.Conry, J.A. and Brown, H. Executive summary, Well-Woman Task Force, components of the Well-Woman Visit. Obstet Gynecol. 2015, 126:697701.
7.American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care. 2016, 39(Suppl 1):S94–8. Available at: http://care.diabetesjournals.org/content/39/Supplement_1/S94. Retrieved December 30, 2016.
8.Sawaya, G. Re-envisioning the annual Well-Woman Visit: The task forward. Obstet Gynecol. 2015, 126(4):695–6.